Search results
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 20 hours agoWhile AstraZeneca is betting big on its newly licensed drug, the product is still in early trials,...
How Neurocrine, An IBD 50 Stock, Is Stacking Up Wins In 2024 — And Outperforming Peers
Investor's Business Daily· 23 minutes agoBut he sees only a 40% chance it eventually gains approval. Still, he raised his price target on the...
Wall Street Analysts See Upside Potential for 10 Stocks with Rising Price Targets
Insider Monkey via Yahoo Finance· 24 hours agoIn this article, we will discuss the 10 stocks whose price targets were recently raised by analysts....
Forget Nvidia: These 3 Small-Cap Stocks Offer Up to 557% Upside, According to Select Wall Street...
Motley Fool via Yahoo Finance· 7 hours agoFood and Drug Administration. This combo vaccine would almost certainly be a better revenue driver...
A TSX Stock I’d Avoid at All Costs
MSN News· 20 hours agoDespite posting a massive surge in share prices, Canopy Growth (TSX:WEED) is a stock you might be better off steering clear of. The post A TSX Stock I’d...
‘Ozempic babies’: Reports of surprise pregnancies raise new questions about weight loss drugs | CNN
CNN.com· 22 hours agoNumerous women have shared stories of “Ozempic babies” on social media. But the joy some experience...
Analyst unveils Amgen stock price target after weight-loss drug data
TheStreet via Yahoo Finance· 6 days ago-based company reported first-quarter results on Thursday, including an update on its weight loss ...
Iovance (IOVA) stock price could jump by 30% after earnings
Invezz· 3 days agoIovance Biotherapeutics (NASDAQ: IOVA) stock price has rebounded sharply in the past few days as...
5 ways to keep inflation from wrecking your retirement
Bankrate via AOL· 2 days agoChasing higher yields to combat inflation can be a recipe for disaster, so be sure that you’re not...
Novo Nordisk, ING, Shell: European Stocks in the Spotlight
The Wall Street Journal· 7 days ago↘️ **Novo Nordisk (DK: NOVO.B**, **NVO)**: Europe's most valuable company raised its annual guidance...
